Last 13 quarters of trend data · Healthcare · Medical - Instruments & Supplies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 0.19 | 1.01 | 0.41 | 1.39 | 1.94 | 2.38 | — | 4.57 | — | — | — | — | — | — |
| — | -57.3% | — | -69.7% | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.02 | 0.08 | 0.05 | 0.14 | 0.18 | 0.35 | 1.02 | 0.55 | — | — | — | — | — | — |
| — | -76.3% | -95.2% | -73.9% | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 0.01 | 0.08 | 0.06 | 0.17 | 0.24 | 0.49 | 1.43 | 0.85 | — | — | — | — | — | — |
| — | -84.2% | -95.5% | -79.5% | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | 0.14 | — | 0.19 | 6.51 | 1.18 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | -0.40 | 0.62 | 0.06 | 0.79 | 1.12 | 1.53 | 19.48 | 2.63 | — | — | — | — | — | — |
| — | -59.7% | -99.7% | -70.1% | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | -0.41 | 0.67 | 0.06 | 0.83 | 1.16 | 1.56 | 20.17 | 2.55 | — | — | — | — | — | — |
| — | -57.1% | -99.7% | -67.6% | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 34.4% | 33.2% | 35.0% | 33.4% | 32.7% | 35.5% | 35.5% | 38.1% | 38.4% | 37.7% | 39.3% | 43.9% | 39.2% | 41.0% |
| — | -6.4% | -1.4% | -12.4% | -14.9% | -5.8% | -9.8% | -13.2% | -2.1% | -8.0% | — | — | — | — | |
| Operating Margin | 14.8% | 8.5% | 16.3% | 13.0% | 11.4% | 18.9% | 4.4% | 15.8% | 26.5% | 23.7% | 23.3% | 29.5% | 19.9% | 27.6% |
| — | -54.8% | +271.3% | -17.8% | -57.0% | -20.5% | -81.2% | -46.5% | +33.2% | -13.8% | — | — | — | — | |
| Net Margin | 11.2% | 8.3% | 11.9% | 10.4% | 9.3% | 14.7% | -0.6% | 12.0% | 21.3% | 18.8% | 19.4% | 23.5% | 15.7% | 22.0% |
| — | -43.5% | +1947.9% | -13.0% | -56.2% | -22.1% | -103.3% | -49.1% | +35.6% | -14.7% | — | — | — | — |
| Metric | TTM | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 7.1% | 1.9% | 4.0% | 3.2% | 3.2% | 5.1% | -0.2% | 5.3% | 11.8% | 10.1% | 11.4% | 15.7% | 10.1% | 22.9% |
| — | -61.8% | +1886.5% | -39.6% | -72.9% | -49.9% | -101.9% | -66.5% | +16.6% | -55.7% | — | — | — | — | |
| ROA | 6.1% | 1.7% | 3.4% | 2.7% | 2.7% | 4.3% | -0.2% | 4.3% | 9.3% | 8.1% | 9.0% | 12.5% | 7.2% | — |
| — | -61.5% | +1867.8% | -38.1% | -70.6% | -46.5% | -102.1% | -65.2% | +29.4% | — | — | — | — | — | |
| ROIC | 7.4% | 1.6% | 4.3% | 3.2% | 3.1% | 5.5% | 1.4% | 6.0% | 11.3% | 9.9% | 11.0% | 17.4% | 9.5% | 16.1% |
| — | -71.7% | +211.7% | -47.3% | -72.1% | -44.5% | -87.5% | -65.5% | +19.1% | -38.3% | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.05 | 0.07 | 0.05 | 0.08 | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | 0.04 | 0.06 | 0.04 | — |
| — | +34.9% | +1.7% | +102.1% | +3.0% | -4.7% | +29.4% | -36.2% | +11.9% | — | — | — | — | — | |
| Debt / EBITDA | 0.53 | 3.26 | 0.91 | 1.90 | 1.27 | 0.76 | 2.98 | 0.63 | 0.34 | 0.43 | 0.29 | 0.33 | 0.37 | — |
| — | +326.9% | -69.3% | +203.0% | +271.3% | +76.1% | +912.7% | +92.3% | -8.2% | — | — | — | — | — | |
| Current Ratio | 5.26 | 5.71 | 5.26 | 4.78 | 5.27 | 5.70 | 5.60 | 5.45 | 3.24 | 3.34 | 3.17 | 2.66 | 3.88 | — |
| — | +0.2% | -6.0% | -12.3% | +62.9% | +70.3% | +76.6% | +105.1% | -16.6% | — | — | — | — | — | |
| Quick Ratio | 5.21 | 5.66 | 5.21 | 4.74 | 5.21 | 5.62 | 5.55 | 5.40 | 3.20 | 3.29 | 3.11 | 2.57 | 3.81 | — |
| — | +0.7% | -6.2% | -12.2% | +63.0% | +71.0% | +78.6% | +110.0% | -16.0% | — | — | — | — | — | |
| Interest Coverage | 9.50 | 13.19 | — | 22.79 | 22.90 | 70.53 | 22.25 | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 13 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MHUA stock.
Meihua International Medical Technologies Co., Ltd.'s current P/E is 0.2x. The average P/E over the last 4 quarters is 1.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Meihua International Medical Technologies Co., Ltd.'s current operating margin is 14.8%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Meihua International Medical Technologies Co., Ltd.'s business trajectory between earnings reports.